@article {8064,
	title = {Myocardial adrenergic denervation in patients with primary (AL) amyloidosis},
	journal = {Amyloid},
	volume = {10},
	year = {2003},
	note = {Cited By :4Export Date: 21 February 2017},
	month = {2003},
	pages = {117 - 120},
	abstract = {Three patients, 2 women and 1 man, with primary (AL) amyloidosis without congestive heart failure are described; all 3 patients presented reduced I-123 metaiodobenzylguanidine(MIBG) myocardial uptake suggesting marked cardiac sympathetic denervation. This is the first time myocardial adrenergic denervation is described in patients with AL amyloidosis without evidence of congestive heart failure; the observed denervation could be implicated in the pathogenesis of cardiac conduction disturbances which are common in this disease.},
	keywords = {AL amyloidosis, MIBG},
	url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-0042703599\&partnerID=40\&md5=2e0a06ebf64f75259619816528aa139e},
	author = {Lekakis, J. and Dimopoulos, M.A. and Prassopoulos, V. and Mavrikakis, M. and Gerali, S. and Sifakis, N. and Athanassoulis, T. and Stamatelopoulos, S.}
}
